The Pharma Wholesale and Distribution Market Report 2022-2032: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.
Pharmaceutical Wholesaler and Distributor Anticipated to Meet the Needs of Ongoing & Changing Need for Healthcare Sector
Pharmaceutical wholesaler and distributor are anticipated to meet the needs of the new worldwide market prospects brought on by an ongoing and changing need for healthcare sector. The pharmaceutical industry has traditionally played a significant role in meeting the distribution demands of pharmaceutical businesses. The pharmaceutical business is vast. The pharmaceutical industry is mainly focused on retail, and the majority of businesses are dispersed. The majority of pharmaceutical companies offer their goods in their own nationwide centres. Due to growing market demands, the sector is continually evolving. Pharmaceutical producers sell their products directly to wholesale drug wholesalers. Pharmacy purchases the drugs from the wholesale distributor of pharmaceuticals. Pharmaceutical distributors who offer full service provide their customers with a range of goods and services to fulfil their demands. Independent pharmacists and home care businesses can save money and important time by working with a pharmaceutical source that offers goods like wholesale medications and over-the-counter painkillers.
To Increase Productivity, Businesses Must Spend Money on Monitoring Software to Avoid Interruption of the Supply Chain
In any industry, the supply chain can experience issues. Supply networks have experienced an unprecedented upheaval globally. In actuality, this is one of the biggest issues facing the pharmaceutical industry right now. Although pharmaceutical company management works hard to optimise processes for maximum effectiveness, unforeseen technological issues could cause the entire industry to be delayed. As a result, they modify their strategy and employ their resources to lessen the issues throughout the supply chain. Businesses must invest in monitoring software if they want to increase productivity. In actuality, the monitoring software will help in locating the items and assessing the supply chain's condition.
What Questions Should You Ask before Buying a Market Research Report?
• How is the pharma wholesale and distribution market evolving?
• What is driving and restraining the pharma wholesale and distribution market?
• How will each pharma wholesale and distribution submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2032?
• How will the market shares for each pharma wholesale and distribution submarket develop from 2022 to 2032?
• What will be the main driver for the overall market from 2022 to 2032?
• Will leading pharma wholesale and distribution markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
• How will the market shares of the national markets change by 2032 and which geographical region will lead the market in 2032?
• Who are the leading players and what are their prospects over the forecast period?
• What are the pharma wholesale and distribution projects for these leading companies?
• How will the industry evolve during the period between 2022 and 2032? What are the implications of pharma wholesale and distribution projects taking place now and over the next 10 years?
• Is there a greater need for product commercialisation to further scale the pharma wholesale and distribution market?
• Where is the pharma wholesale and distribution market heading and how can you ensure you are at the forefront of the market?
• What are the best investment options for new product and service lines?
• What are the key prospects for moving companies into a new growth path and C-suite?
You need to discover how this will impact the pharma wholesale and distribution market today, and over the next 10 years:
• Our 362-page report provides 176 tables and 149 charts/graphs exclusively to you.
• The report highlights key lucrative areas in the industry so you can target them – NOW.
• It contains in-depth analysis of global, regional and national sales and growth.
• It highlights for you the key successful trends, changes and revenue projections made by your competitors.
This report tells you TODAY how the pharma wholesale and distribution market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.
Forecasts to 2032 and other analyses reveal commercial prospects
• In addition to revenue forecasting to 2032, our new study provides you with recent results, growth rates, and market shares.
• You will find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising pharma wholesale and distribution prices and recent developments.
This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, “V”, “L”, “W” and “U” are discussed in this report.
Segments Covered in the Report
Distributor Type
• Ethical/Branded Pharma Products Distributors
• Generic Pharma Products Distributors
• Propaganda Cum Distribution (PCD) Franchise
• OTC/Institutional Supply Pharma Distributors
• Other Distributor Types
Type
• Full-Line Wholesalers (FLWs)
• Short-Line Wholesalers (SLWs)
• Direct-to-Pharmacy (DTP)
• Hospitals, Clinics & Others
• Mail Orders
• Other Types
Product Type
• Prescription Drugs Wholesaling & Distribution
• Antibiotics Wholesaling & Distribution
• OTC Products Wholesaling & Distribution
• Antiseptics Wholesaling & Distribution
• Supplement Products Wholesaling & Distribution
• Other Product Types
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 25 leading national markets:
North America
• U.S.
• Canada
Europe
• Germany
• France
• UK
• Italy
• Spain
• Russia
• UK
• The Netherlands
• Denmark
• Finland
• Rest of Europe
Asia Pacific
• China
• India
• Japan
• South Korea
• Australia
• Indonesia
• Malaysia
• Rest of Asia Pacific
Latin America
• Brazil
• Mexico
• Argentina
• Rest of Latin America
MEA
• Saudi Arabia
• Turkey
• UAE
• South Africa
• Rest of MEA
The report also includes profiles and for some of the leading companies in the Pharma Wholesale and Distribution Market, 2022 to 2032, with a focus on this segment of these companies’ operations.
Leading companies and the potential for market growth
• Alfresa Holdings
• AmerisourceBergen Corporation
• Cardinal Health, Inc.
• China Resources Pharmaceutical Group Limited
• CuraScript SD
• Dakota Drug Inc.
• Fortissa
• Fosun International
• Geo-Young Corporation
• Kingworld Medicines Group Ltd.
• Mawdsley-Brooks
• McKesson Corporation
• Medipal Holdings Corporation
• Morris and Dickson
• Mutual Drug Company
• Ohki Healthcare Holdings Co., Ltd
• Petrone Group
• PHOENIX Group
• Prodigy Health
• Profarma Distribuidora de Produtos Farmaceuticos SA
• Realcan Pharmaceutical Group Co.
• Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
• Sinopharm Group Co. Ltd.
• Smith Drug Company
• Suzuken Co Ltd.
• Walgreens Boots Alliance, Inc.
• Zhejiang Int’l Group Co. Ltd
Overall world revenue for Pharma Wholesale and Distribution Market, 2022 to 2032 in terms of value the market will surpass US$548 billion in 2022, our work calculates. We predict strong revenue growth through to 2032. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
How will the Pharma Wholesale and Distribution Market, 2022 to 2032 report help you?
In summary, our 360+ page report provides you with the following knowledge:
• Revenue forecasts to 2032 for Pharma Wholesale and Distribution Market, 2022 to 2032 Market, with forecasts for product type, distributor type, and type, each forecast at a global and regional level – discover the industry’s prospects, finding the most lucrative places for investments and revenues.
• Revenue forecasts to 2032 for five regional and 20 key national markets – See forecasts for the Pharma Wholesale and Distribution Market, 2022 to 2032 market in North America, Europe, Asia-Pacific and Latin America and MEA Also forecasted is the market in the U.S. , Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
• Prospects for established firms and those seeking to enter the market – including company profiles for 27 of the major companies involved in the Pharma Wholesale and Distribution Market, 2022 to 2032.
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.
Information found nowhere else
With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Our study is for everybody needing commercial analyses for the Pharma Wholesale and Distribution Market, 2022 to 2032, market-leading companies. You will find data, trends and predictions.
'
1 Report Overview
1.1 Objectives of the Study
1.2 Introduction to Pharma Wholesale and Distribution Market
1.3 What This Report Delivers
1.4 Why You Should Read This Report
1.5 Key Questions Answered by This Analytical Report Include:
1.6 Who is This Report For?
1.7 Methodology
1.7.1 Market Definitions
1.7.2 Market Evaluation & Forecasting Methodology
1.7.5.1 Primary Research
1.7.5.1 Secondary Research
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Reports
1.10 About
2 Executive Summary
3 Market Structure
3.1 Supply Chain
3.1.5.1 Growth and Complexity
3.1.5.1 Infrastructure improvement: Self-care for Expanding Supply Chains
3.1.5.1 From Raw Data to Meaningful Insights, Complexity is Decreasing
3.1.5.1 Driving Performance: Aligned Business Drivers
3.1.5.1 Utilising Resources from External Consultancies
3.2 Value Chain
3.2.5.1 Producing the Medicines
3.2.5.1 Distribution to the Dispensing Point
3.2.5.1 Dispensing to the end user
3.3 Recent Trends/ Developments
3.3.5.1 Artificial Intelligence (AI)
3.3.5.1 Analytics & Big Data
3.3.5.1 Medical Precision
3.3.5.1 Dynamic Production
3.3.5.1 Therapeutic Procedures
4 Market Overview
4.1 Market Dynamics
4.2 Market Driving Factors
4.2.1 Diseases Caused by Pollution
4.2.2 Adapting To New Lifestyles
4.2.1 Increase In Maintenance and Cost Control
4.3 Market Restraining Factors
4.3.1 Supply Chain Disruptions Involving A Single or Double Source Have A Greater Impact On The Market
4.3.2 Distributors Must Possess a Licence in Order to Be An Authorized Trading Partner
4.3.3 Pharmacological And Physical Restraints in Hospital Care
4.4 Market Opportunities
4.4.1 From Raw Data to Operating Analytics, Complexity Decreases
4.4.2 Utilizing External Consulting Services
4.4.3 Growth Owing to a Rise in Subsidized Spending Through Programs
4.5 Market Challenges
4.5.1 Large-Scale Data Gathering and Analysis
4.5.2 Interruption of The Supply Chain
4.5.3 Increasing Customer Demands and Challenges in Maintaining Brand Health
4.6 COVID-19 Impact Analysis
4.7 SWOT Analysis
4.7.1 Market Strengths
4.7.2 Market Weaknesses
4.7.3 Market Opportunities
4.7.4 Market Threats
4.8 Porter’s Five Forces Analysis
4.8.1 Supplier Power
4.8.2 Buyer Power
4.8.3 Competitive Rivalry
4.8.4 Threat from Substitutes
4.8.5 Threat of New Entrants
4.9 PESTLE Analysis
4.9.1 Political Factors
4.9.2 Economic Factors
4.9.3 Social Factors
4.9.4 Technology Factors
4.9.5 Legal Factors
4.9.6 Environmental Factors
5 Pharma Wholesale and Distribution Market Analysis
5.1 Pharma Wholesale and Distribution Overview
5.2 Pharmaceutical Manufacturing Market
5.3 Logistic Distribution of Pharmaceutical Market
5.4 Subdivisions of The World Pharma Business
6 Pharma Wholesale and Distribution Market Analysis by Type
6.1 Segment Overview
6.1.1 Full-Line Wholesalers (FLWs)
6.1.2 Short-Line Wholesalers (SLWs)
6.1.3 Direct-to-Pharmacy (DTP)
6.1.4 Hospitals, Clinics & Others
6.1.5 Mail Orders
6.1.6 Other Types
6.2 Market Size Estimation and Forecast by Type
7 Pharma Wholesale and Distribution Market Analysis by Product Type
7.1 Segment Overview
7.1.1 Prescription Drugs Wholesaling & Distribution
7.1.2 OTC Products Wholesaling & Distribution
7.1.3 Antibiotics Wholesaling & Distribution
7.1.4 Antiseptics Wholesaling & Distribution
7.1.5 Supplement Products Wholesaling & Distribution
7.1.6 Other Product Types
7.2 Market Size Estimation and Forecast by Product Type
8 Pharma Wholesale and Distribution Market Analysis by Distributor Type
8.1 Segment Overview
8.1.1 Ethical/Branded Pharma Products Distributors
8.1.2 Generic Pharma Products Distributors
8.1.3 Propaganda Cum Distribution (PCD) Franchise
8.1.4 OTC/Institutional Supply Pharma Distributors
8.1.5 Other Distributor Types
8.2 Market Size Estimation and Forecast by Distributor Type
9 North America Pharma Wholesale and Distribution Market Analysis
9.1 North America Market Size Estimation and Forecast by Value
9.2 Market Size Estimation and Forecast by Country
9.3 Market Size Estimation and Forecast by Product Type
9.4 Market Size Estimation and Forecast by Distributor Type
9.5 Market Size Estimation and Forecast by Type
9.6 U.S. Market Analysis
9.7 Canada Market Analysis
10 Europe Pharma Wholesale and Distribution Market Analysis
10.1 Europe Market Outlook
10.2 Market Size Estimation and Forecast by Value
10.3 Market Size Estimation and Forecast by Country
10.4 Market Size Estimation and Forecast by Product Type
10.5 Market Size Estimation and Forecast by Distributor Type
10.6 Market Size Estimation and Forecast by Type
10.7 Germany Market Analysis
10.8 France Market Analysis
10.9 UK Market Analysis
10.10 Italy Market Analysis
10.11 Spain Market Analysis
10.12 Finland Market Analysis
10.13 Russia Market Analysis
10.14 The Netherlands Market Analysis
10.15 Denmark Market Analysis
10.16 Rest of Europe Market Analysis
11 Asia-Pacific Pharma Wholesale and Distribution Market Analysis
11.1 Asia- Pacific Market Outlook
11.2 Market Size Estimation and Forecast by Value
11.3 Market Size Estimation and Forecast by Country
11.4 Market Size Estimation and Forecast by Product Type
11.5 Market Size Estimation and Forecast by Distributor Type
11.6 Market Size Estimation and Forecast by Type
11.7 China Market Analysis
11.8 India Market Analysis
11.9 Japan Market Analysis
11.10 South Korea Market
11.11 Australia Market Analysis
11.12 Indonesia Market Analysis
11.13 Malaysia Market Analysis
11.14 Rest of Asia-Pacific Market Analysis
12 Latin America Pharma Wholesale and Distribution Market Analysis
12.1 Latin America Outlook
12.2 Market Size Estimation and Forecast by Value
12.3 Market Size Estimation and Forecast by Country
12.4 Market Size Estimation and Forecast by Product Type
12.5 Market Size Estimation and Forecast by Distributor Type
12.6 Market Size Estimation and Forecast by Type
12.7 Brazil Market Analysis
12.8 Mexico Market Analysis
12.9 Argentina Market Analysis
12.10 Rest of Latin America Market Analysis
13 Middle East & Africa Pharma Wholesale and Distribution Market Analysis
13.1 Middle East & Africa Market Outlook
13.2 Market Size Estimation and Forecast by Value
13.3 Market Size Estimation and Forecast by Country
13.4 Market Size Estimation and Forecast by Product Type
13.5 Market Size Estimation and Forecast by Distributor Type
13.6 Market Size Estimation and Forecast by Type
13.7 Saudi Arabia Market Analysis
13.8 Turkey Market Analysis
13.9 UAE Market Analysis
13.10 South Africa Market Analysis
13.11 Rest of Middle East and Africa Market Analysis
14 Company Profiles
14.1 Strategic Framework
14.2 Morris and Dickson
14.2.1 Company Snapshot
14.2.2 Company Overview
14.2.3 Financial Analysis
14.2.4 Company Product Benchmarking
14.2.5 Strategic Outlook
14.3 Alfresa Holdings
14.3.1 Company Snapshot
14.3.2 Company Overview
14.3.3 Financial Analysis
14.3.4 Company Product Benchmarking
14.3.5 Strategic Outlook
14.4 Walgreens Boots Alliance, Inc
14.4.1 Company Snapshot
14.4.2 Company Overview
14.4.3 Financial Analysis
14.4.4 Company Product Benchmarking
14.4.5 Strategic Outlook
14.5 AmerisourceBergen Corporation
14.5.1 Company Snapshot
14.5.2 Company Overview
14.5.3 Financial Analysis
14.5.4 Company Product Benchmarking
14.5.5 Strategic Outlook
14.6 Sinopharm Group Co. Ltd
14.6.1 Company Snapshot
14.6.2 Company Overview
14.6.3 Financial Analysis
14.6.4 Company Product Benchmarking
14.6.5 Strategic Outlook
14.7 Suzuken Co Ltd
14.7.1 Company Snapshot
14.7.2 Company Overview
14.7.3 Financial Analysis
14.7.4 Company Product Benchmarking
14.7.5 Strategic Outlook
14.8 Shanghai Fosun Pharmaceutical (Group) Co., Ltd
14.8.1 Company Snapshot
14.8.2 Company Overview
14.8.3 Financial Analysis
14.8.4 Company Product Benchmarking
14.8.5 Strategic Outlook
14.9 China Resources Pharmaceutical Group Limited
14.9.1 Company Snapshot
14.9.2 Company Overview
14.9.3 Financial Analysis
14.9.4 Company Product Benchmarking
14.9.5 Strategic Outlook
14.10 Smith Drug Company
14.10.1 Company Snapshot
14.10.2 Company Overview
14.10.3 Company Product Benchmarking
14.11 CuraScript SD
14.11.1 Company Snapshot
14.11.2 Company Overview
14.11.3 Company Product Benchmarking
14.12 Cardinal Health, Inc.
14.12.1 Company Snapshot
14.12.2 Company Overview
14.12.3 Financial Analysis
14.12.4 Company Product Benchmarking
14.12.5 Strategic Outlook
14.13 Fosun International
14.13.1 Company Snapshot
14.13.2 Company Overview
14.13.3 Financial Analysis
14.13.4 Product Benchmarking
14.13.5 Strategic Outlook
14.14 Mutual Drug Company
14.14.1 Company Snapshot
14.14.2 Company Overview
14.14.3 Company Product Benchmarking
14.15 McKesson Corporation
14.15.1 Company Snapshot
14.15.2 Company Overview
14.15.3 Financial Analysis
14.15.4 Company Product Benchmarking
14.15.5 Strategic Outlook
14.16 Medipal Holdings Corporation
14.16.1 Company Snapshot
14.16.2 Company Overview
14.16.3 Financial Analysis
14.16.4 Company Product Benchmarking
14.16.5 Strategic Outlook
14.17 PHOENIX Group
14.17.1 Company Snapshot
14.17.2 Company Overview
14.17.3 Financial Analysis
14.17.4 Company Product Benchmarking
14.17.5 Strategic Outlook
14.18 Mawdsley-Brooks
14.18.1 Company Snapshot
14.18.2 Company Overview
14.18.3 Company Product Benchmarking
14.19 Prodigy Health
14.19.1 Company Snapshot
14.19.2 Company Overview
14.19.3 Company Product Benchmarking
14.20 Geo-Young Corporation
14.20.1 Company Snapshot
14.20.2 Company Overview
14.20.3 Product Benchmarking
14.20.4 Strategic Outlook
14.21 Kingworld Medicines Group Ltd
14.21.1 Company Snapshot
14.21.2 Company Overview
14.21.3 Product Benchmarking
14.21.4 Strategic Outlook
14.22 Profarma Distribuidora de Produtos Farmaceuticos SA
14.22.1 Company Snapshot
14.22.2 Company Overview
14.22.3 Financial Analysis
14.22.4 Product Benchmarking
14.23 Petrone Group
14.23.1 Company Snapshot
14.23.2 Company Overview
14.23.3 Product Benchmarking
14.23.4 Strategic Outlook
14.24 Realcan Pharmaceutical Group Co
14.24.1 Company Snapshot
14.24.2 Company Overview
14.24.3 Financial Analysis
14.24.4 Product Benchmarking
14.24.5 Strategic Outlook
14.25 Dakota Drug Inc.
14.25.1 Company Snapshot
14.25.2 Company Overview
14.25.3 Product Benchmarking
14.26 Zhejiang Int’l Group Co. Ltd
14.26.1 Company Snapshot
14.26.2 Company Overview
14.26.3 Financial Analysis
14.26.4 Product Benchmarking
14.27 Ohki Healthcare Holdings Co., Ltd
14.27.1 Company Snapshot
14.27.2 Company Overview
14.27.3 Financial Analysis
14.27.4 Product Benchmarking
14.27.5 Strategic Outlook
14.28 Fortissa
14.28.1 Company Snapshot
14.28.2 Company Overview
14.28.3 Company Product Benchmarking
15 Conclusion and Recommendations
List of Tables
Table 1 Pharma Wholesale and Distribution Market Snapshot, 2022 & 2032 (US$ billion, CAGR %)
Table 2 Pharma Wholesale and Distribution Market Forecast, 2022-2032 (US$ Bn, AGR (%), CAGR(%)) (V-Shaped Recovery Scenario)
Table 3 Pharma Wholesale and Distribution Market by Region, 2022-2032 (US$ Bn, AGR (%), CAGR(%)) (V-Shaped Recovery Scenario)
Table 4 Pharma Wholesale and Distribution Market Forecast, 2022-2032 (US$ Bn, AGR (%), CAGR(%)) (W-Shaped Recovery Scenario)
Table 5 Pharma Wholesale and Distribution Market by Region, 2022-2032 (US$ Bn, AGR (%), CAGR(%)) (W-Shaped Recovery Scenario)
Table 6 Pharma Wholesale and Distribution Market Forecast, 2022-2032 (US$ Bn, AGR (%), CAGR(%)) (U-Shaped Recovery Scenario)
Table 7 Pharma Wholesale and Distribution Market by Region, 2022-2032 (US$ Bn, AGR (%), CAGR(%)) (U-Shaped Recovery Scenario)
Table 8 Pharma Wholesale and Distribution Market Forecast, 2022-2032 (US$ Bn, AGR (%), CAGR(%)) (L-Shaped Recovery Scenario)
Table 9 Pharma Wholesale and Distribution Market by Region, 2022-2032 (US$ Bn, AGR (%), CAGR(%)) (L-Shaped Recovery Scenario)
Table 10 Pharma Wholesale and Distribution Market Forecast, 2022-2032 (US$ Bn, AGR (%), CAGR(%))
Table 11 Pharma Wholesale and Distribution Market by Region, 2022-2032 (US$ Bn, AGR (%), CAGR(%))
Table 12 Pharma Wholesale and Distribution Market by Product Type, 2022-2032 (US$ Bn, AGR (%), CAGR(%))
Table 13 Pharma Wholesale and Distribution Market by Distributor Type, 2022-2032 (US$ Bn, AGR (%), CAGR(%))
Table 14 Pharma Wholesale and Distribution Market by Type, 2022-2032 (US$ Bn, AGR (%), CAGR(%))
Table 15 Pharma Wholesale and Distribution Market by Type, 2022-2032 (US$ Bn, AGR (%), CAGR(%))
Table 16 Full-Line Wholesalers (FLWs) Market Forecast, 2022-2032 (US$ Bn, AGR (%), CAGR(%))
Table 17 Full-Line Wholesalers (FLWs) Market by Region, 2022-2032 (US$ Bn, AGR (%), CAGR(%))
Table 18 Short-Line Wholesalers (SLWs) Market Forecast, 2022-2032 (US$ Bn, AGR (%), CAGR(%))
Table 19 Short-Line Wholesalers (SLWs) Market by Region, 2022-2032 (US$ Bn, AGR (%), CAGR(%))
Table 20 Direct-to-Pharmacy (DTP) Market Forecast, 2022-2032 (US$ Bn, AGR (%), CAGR(%))
Table 21 Direct-to-Pharmacy (DTP) Market by Region, 2022-2032 (US$ Bn, AGR (%), CAGR(%))
Table 22 Hospitals, Clinics & Others Market Forecast, 2022-2032 (US$ Bn, AGR (%), CAGR(%))
Table 23 Hospitals, Clinics & Others Market by Region, 2022-2032 (US$ Bn, AGR (%), CAGR(%))
Table 24 Mail Orders Market Forecast, 2022-2032 (US$ Bn, AGR (%), CAGR(%))
Table 25 Mail Orders Market by Region, 2022-2032 (US$ Bn, AGR (%), CAGR(%))
Table 26 Other Types Market Forecast, 2022-2032 (US$ Bn, AGR (%), CAGR(%))
Table 27 Other Types Market by Region, 2022-2032 (US$ Bn, AGR (%), CAGR(%))
Table 28 Pharma Wholesale and Distribution Market by Product Type, 2022-2032 (US$ Bn, AGR (%), CAGR(%))
Table 29 Prescription Drugs Wholesaling & Distribution Market Forecast, 2022-2032 (US$ Bn, AGR (%), CAGR(%))
Table 30 Prescription Drugs Wholesaling & Distribution Market by Region, 2022-2032 (US$ Bn, AGR (%), CAGR(%))
Table 31 Antibiotics Wholesaling & Distribution Market Forecast, 2022-2032 (US$ Bn, AGR (%), CAGR(%))
Table 32 Antibiotics Wholesaling & Distribution Market by Region, 2022-2032 (US$ Bn, AGR (%), CAGR(%))
Table 33 OTC Products Wholesaling & Distribution Market Forecast, 2022-2032 (US$ Bn, AGR (%), CAGR(%))
Table 34 OTC Products Wholesaling & Distribution Market by Region, 2022-2032 (US$ Bn, AGR (%), CAGR(%))
Table 35 Antiseptics Wholesaling & Distribution Market Forecast, 2022-2032 (US$ Bn, AGR (%), CAGR(%))
Table 36 Antiseptics Wholesaling & Distribution Market by Region, 2022-2032 (US$ Bn, AGR (%), CAGR(%))
Table 37 Supplement Products Wholesaling & Distribution Market Forecast, 2022-2032 (US$ Bn, AGR (%), CAGR(%))
Table 38 Supplement Products Wholesaling & Distribution Market by Region, 2022-2032 (US$ Bn, AGR (%), CAGR(%))
Table 39 Other Product Types Wholesaling & Distribution Market Forecast, 2022-2032 (US$ Bn, AGR (%), CAGR(%))
Table 40 Other Product Types Wholesaling & Distribution Market by Region, 2022-2032 (US$ Bn, AGR (%), CAGR(%))
Table 41 Pharma Wholesale and Distribution Market by Distributor Type, 2022-2032 (US$ Bn, AGR (%), CAGR(%))
Table 42 Ethical/Branded Pharma Products Distributors Market Forecast, 2022-2032 (US$ Bn, AGR (%), CAGR(%))
Table 43 Ethical/Branded Pharma Products Distributors Market by Region, 2022-2032 (US$ Bn, AGR (%), CAGR(%))
Table 44 Generic Pharma Products Distributors Market Forecast, 2022-2032 (US$ Bn, AGR (%), CAGR(%))
Table 45 Generic Pharma Products Distributors Market by Region, 2022-2032 (US$ Bn, AGR (%), CAGR(%))
Table 46 Propaganda Cum Distribution (PCD) Franchise Market Forecast, 2022-2032 (US$ Bn, AGR (%), CAGR(%))
Table 47 Propaganda Cum Distribution (PCD) Franchise Market by Region, 2022-2032 (US$ Bn, AGR (%), CAGR(%))
Table 48 OTC/Institutional Supply Pharma Distributors Market Forecast, 2022-2032 (US$ Bn, AGR (%), CAGR(%))
Table 49 OTC/Institutional Supply Pharma Distributors Market by Region, 2022-2032 (US$ Bn, AGR (%), CAGR(%))
Table 50 Other Distributor Types Market Forecast, 2022-2032 (US$ Bn, AGR (%), CAGR(%))
Table 51 Other Distributor Types Market by Region, 2022-2032 (US$ Bn, AGR (%), CAGR(%))
Table 52 North America Pharma Wholesale and Distribution Market by Value, 2022-2032 (US$ Bn, AGR (%), CAGR(%))
Table 53 North America Pharma Wholesale and Distribution Market by Country, 2022-2032 (US$ Bn, AGR (%), CAGR(%))
Table 54 North America Pharma Wholesale and Distribution Market by Product Type, 2022-2032 (US$ Bn, AGR (%), CAGR(%))
Table 55 North America Pharma Wholesale and Distribution Market by Distributor Type, 2022-2032 (US$ Bn, AGR (%), CAGR(%))
Table 56 North America Pharma Wholesale and Distribution Market by Type, 2022-2032 (US$ Bn, AGR (%), CAGR(%))
Table 57 US Pharma Wholesale and Distribution Market by Value, 2022-2032 (US$ Bn, AGR (%), CAGR(%))
Table 58 Canada Pharma Wholesale and Distribution Market by Value, 2022-2032 (US$ Bn, AGR (%), CAGR(%))
Table 59 Europe Pharma Wholesale and Distribution Market by Value, 2022-2032 (US$ Bn, AGR (%), CAGR(%))
Table 60 Europe Pharma Wholesale and Distribution Market by Country, 2022-2032 (US$ Bn, AGR (%), CAGR(%))
Table 61 Europe Pharma Wholesale and Distribution Market by Product Type, 2022-2032 (US$ Bn, AGR (%), CAGR(%))
Table 62 Europe Pharma Wholesale and Distribution Market by Distributor Type, 2022-2032 (US$ Bn, AGR (%), CAGR(%))
Table 63 Europe Pharma Wholesale and Distribution Market by Type, 2022-2032 (US$ Bn, AGR (%), CAGR(%))
Table 64 Germany Pharma Wholesale and Distribution Market by Value, 2022-2032 (US$ Bn, AGR (%), CAGR(%))
Table 65 France Pharma Wholesale and Distribution Market by Value, 2022-2032 (US$ Bn, AGR (%), CAGR(%))
Table 66 UK Pharma Wholesale and Distribution Market by Value, 2022-2032 (US$ Bn, AGR (%), CAGR(%))
Table 67 Italy Pharma Wholesale and Distribution Market by Value, 2022-2032 (US$ Bn, AGR (%), CAGR(%))
Table 68 Spain Pharma Wholesale and Distribution Market by Value, 2022-2032 (US$ Bn, AGR (%), CAGR(%))
Table 69 Finland Pharma Wholesale and Distribution Market by Value, 2022-2032 (US$ Bn, AGR (%), CAGR(%))
Table 70 Russia Pharma Wholesale and Distribution Market by Value, 2022-2032 (US$ Bn, AGR (%), CAGR(%))
Table 71 The Netherlands Pharma Wholesale and Distribution Market by Value, 2022-2032 (US$ Bn, AGR (%), CAGR(%))
Table 72 Denmark Pharma Wholesale and Distribution Market by Value, 2022-2032 (US$ Bn, AGR (%), CAGR(%))
Table 73 Rest of Europe Pharma Wholesale and Distribution Market by Value, 2022-2032 (US$ Bn, AGR (%), CAGR(%))
Table 74 Asia-Pacific Pharma Wholesale and Distribution Market by Value, 2022-2032 (US$ Bn, AGR (%), CAGR(%))
Table 75 Asia-Pacific Pharma Wholesale and Distribution Market by Country, 2022-2032 (US$ Bn, AGR (%), CAGR(%))
Table 76 Asia-Pacific Pharma Wholesale and Distribution Market by Product Type, 2022-2032 (US$ Bn, AGR (%), CAGR(%))
Table 77 Asia-Pacific Pharma Wholesale and Distribution Market by Distributor Type, 2022-2032 (US$ Bn, AGR (%), CAGR(%))
Table 78 Asia-Pacific Pharma Wholesale and Distribution Market by Type, 2022-2032 (US$ Bn, AGR (%), CAGR(%))
Table 79 China Pharma Wholesale and Distribution Market by Value, 2022-2032 (US$ Bn, AGR (%), CAGR(%))
Table 80 India Pharma Wholesale and Distribution Market by Value, 2022-2032 (US$ Bn, AGR (%), CAGR(%))
Table 81 Japan Pharma Wholesale and Distribution Market by Value, 2022-2032 (US$ Bn, AGR (%), CAGR(%))
Table 82 South Korea Pharma Wholesale and Distribution Market by Value, 2022-2032 (US$ Bn, AGR (%), CAGR(%))
Table 83 Australia Pharma Wholesale and Distribution Market by Value, 2022-2032 (US$ Bn, AGR (%), CAGR(%))
Table 84 Indonesia Pharma Wholesale and Distribution Market by Value, 2022-2032 (US$ Bn, AGR (%), CAGR(%))
Table 85 Malaysia Pharma Wholesale and Distribution Market by Value, 2022-2032 (US$ Bn, AGR (%), CAGR(%))
Table 86 Rest of Asia-Pacific Pharma Wholesale and Distribution Market by Value, 2022-2032 (US$ Bn, AGR (%), CAGR(%))
Table 87 Latin America Pharma Wholesale and Distribution Market by Value, 2022-2032 (US$ Bn, AGR (%), CAGR(%))
Table 88 Latin America Pharma Wholesale and Distribution Market by Country, 2022-2032 (US$ Bn, AGR (%), CAGR(%))
Table 89 Latin America Pharma Wholesale and Distribution Market by Product Type, 2022-2032 (US$ Bn, AGR (%), CAGR(%))
Table 90 Latin America Pharma Wholesale and Distribution Market by Distributor Type, 2022-2032 (US$ Bn, AGR (%), CAGR(%))
Table 91 Latin America Pharma Wholesale and Distribution Market by Type, 2022-2032 (US$ Bn, AGR (%), CAGR(%))
Table 92 Brazil Pharma Wholesale and Distribution Market by Value, 2022-2032 (US$ Bn, AGR (%), CAGR(%))
Table 93 Mexico Pharma Wholesale and Distribution Market by Value, 2022-2032 (US$ Bn, AGR (%), CAGR(%))
Table 94 Argentina Pharma Wholesale and Distribution Market by Value, 2022-2032 (US$ Bn, AGR (%), CAGR(%))
Table 95 Rest of Latin America Pharma Wholesale and Distribution Market by Value, 2022-2032 (US$ Bn, AGR (%), CAGR(%))
Table 96 Middle East & Africa Pharma Wholesale and Distribution Market by Value, 2022-2032 (US$ Bn, AGR (%), CAGR(%))
Table 97 Middle East & Africa Pharma Wholesale and Distribution Market by Country, 2022-2032 (US$ Bn, AGR (%), CAGR(%))
Table 98 Middle East & Africa Pharma Wholesale and Distribution Market by Product Type, 2022-2032 (US$ Bn, AGR (%), CAGR(%))
Table 99 Middle East & Africa Pharma Wholesale and Distribution Market by Distributor Type, 2022-2032 (US$ Bn, AGR (%), CAGR(%))
Table 100 Middle East & Africa Pharma Wholesale and Distribution Market by Type, 2022-2032 (US$ Bn, AGR (%), CAGR(%))
Table 101 Saudi Arabia Pharma Wholesale and Distribution Market by Value, 2022-2032 (US$ Bn, AGR (%), CAGR(%))
Table 102 Turkey Pharma Wholesale and Distribution Market by Value, 2022-2032 (US$ Bn, AGR (%), CAGR(%))
Table 103 UAE Pharma Wholesale and Distribution Market by Value, 2022-2032 (US$ Bn, AGR (%), CAGR(%))
Table 104 South Africa Pharma Wholesale and Distribution Market by Value, 2022-2032 (US$ Bn, AGR (%), CAGR(%))
Table 105 Rest of Middle East & Africa Pharma Wholesale and Distribution Market by Value, 2022-2032 (US$ Bn, AGR (%), CAGR(%))
Table 106 Strategic Framework
Table 107 Morris and Dickson.: Company Information
Table 108 Morris and Dickson.: Company Service Benchmarking
Table 109 Morris and Dickson.: Strategic Outlook
Table 110 Alfresa Holdings.: Company Information
Table 111 Alfresa Holdings.: Company Service Benchmarking
Table 112 Alfresa Holdings.: Strategic Outlook
Table 113 Walgreens Boots Alliance, Inc: Company Information
Table 114 Walgreens Boots Alliance, Inc: Company Product and Service Benchmarking
Table 115 Walgreens Boots Alliance, Inc: Strategic Outlook
Table 116 AmerisourceBergen Corporation.: Company Information
Table 117 AmerisourceBergen Corporation.: Company Product and Service
Table 118 AmerisourceBergen Corporation Strategic Outlook
Table 119 Sinopharm Group Co. Ltd: Company Information
Table 120 Sinopharm Group Co. Ltd: Company Product and Service
Table 121 Sinopharm Group Co. Ltd.: Strategic Outlook
Table 122 Suzuken Co Ltd : Company Information
Table 123 Suzuken Co Ltd : Company Product and Service Benchmarking
Table 124 Suzuken Co Ltd: Strategic Outlook
Table 125 Shanghai Fosun Pharmaceutical (Group) Co., Ltd : Company Information
Table 126 Suzuken Co Ltd : Company Product and Service Benchmarking
Table 127 Shanghai Fosun Pharmaceutical (Group) Co., Ltd .: Strategic Outlook
Table 128 China Resources Pharmaceutical Group Limited.: Company Information
Table 129 China Resources Pharmaceutical Group Limited.: Company Service Benchmarking
Table 130 China Resources Pharmaceutical Group Limited.: Strategic Outlook
Table 131 Smith Drug Company: Company Information
Table 132 Smith Drug Company : Company Product and Service Benchmarking
Table 133 CuraScript SD.: Company Information
Table 134 CuraScript SD.: Company Product and Service Benchmarking
Table 135 Cardinal Health, Inc.: Company Information
Table 136 Cardinal Health, Inc.: Company Product and Service Benchmarking
Table 137 Cardinal Health, Inc. Recent Developments
Table 138 Fosun International: Company Information
Table 139 Fosun International: Product Benchmarking
Table 140 Fosun International: Strategic Outlook
Table 141 Mutual drug Company: Company Information
Table 142 Mutual drug Company: Company Product and Service Benchmarking
Table 143 McKesson Corporation.: Company Information
Table 144 McKesson Corporation: Product and Service
Table 145 McKesson Corporation: Recent Developments
Table 146 Medipal Holdings Corporation: Company Information
Table 147 Medipal Holdings Corporation: Company Product and Service
Table 148 Medipal Holdings Corporation.: Strategic Outlook
Table 156 Geo-Young Corporation: Company Information
Table 157 Geo-Young Corporation: Product Benchmarking
Table 158 Geo-Young Corporation: Strategic Outlook
Table 159 Kingworld Medicines Group Ltd: Company Information
Table 160 Kingworld Medicines Group Ltd: Product Benchmarking
Table 161 Kingworld Medicines Group Ltd: Strategic Outlook
Table 162 Profarma Distribuidora de Produtos Farmaceuticos: Company Information
Table 163 Profarma Distribuidora de Produtos Farmaceuticos SA: Product Benchmarking
Table 164 Petrone Group: Company Information
Table 165 Petrone Group: Product Benchmarking
Table 166 Petrone Group: Strategic Outlook
Table 167 Realcan Pharmaceutical Group Co: Company Information
Table 168 Realcan Pharmaceutical Group Co: Product Benchmarking
Table 169 Realcan Pharmaceutical Group Co: Strategic Outlook
Table 170 Dakota Drug Inc.: Company Information
Table 171 Dakota Drug Inc.: Product Benchmarking
Table 172 Zhejiang Int’l Group Co. Ltd: Company Information
Table 173 Zhejiang Int’l Group Co. Ltd: Product Benchmarking
Table 174 Ohki Healthcare Holdings Co., Ltd: Company Information
Table 175 Ohki Healthcare Holdings Co., Ltd: Product Benchmarking
Table 176 Ohki Healthcare Holdings Co., Ltd: Strategic Outlook
List of Figures
Figure 1 Pharma Wholesale and Distribution Market Segmentation
Figure 2 Pharma Wholesale and Distribution Market Forecast by Region: Market Attractiveness Index
Figure 3 Pharma Wholesale and Distribution Market by Type: Market Attractiveness Index
Figure 4 Pharma Wholesale and Distribution Market by Distributor Type: Market Attractiveness Index
Figure 5 Schematic of levels of pharmaceutical supply chains in emerging markets.
Figure 6 Schematic of three main types of pharmaceutical value chains in emerging markets.
Figure 7 Pharma Wholesale and Distribution Market: Market Dynamics
Figure 8 COVID Impact Analysis: Pharma Wholesale and Distribution Market Recovery Scenarios
Figure 9 Pharma Wholesale and Distribution Market Forecast, 2022-2032 (US$ Bn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 10 Pharma Wholesale and Distribution Market by Region, 2022-2032 (US$ Bn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 11 Pharma Wholesale and Distribution Market Forecast, 2022-2032 (US$ Bn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 12 Pharma Wholesale and Distribution Market by Region, 2022-2032 (US$ Bn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 13 Pharma Wholesale and Distribution Market Forecast, 2022-2032 (US$ Bn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 14 Pharma Wholesale and Distribution Market by Region, 2022-2032 (US$ Bn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 15 Pharma Wholesale and Distribution Market Forecast, 2022-2032 (US$ Bn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 16 Pharma Wholesale and Distribution Market by Region, 2022-2032 (US$ Bn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 17 Pharma Wholesale and Distribution Market: Porter’s Five Forces Analysis
Figure 18 Pharma Wholesale and Distribution Market Forecast, 2022-2032 (US$ Bn, AGR (%))
Figure 19 Pharma Wholesale and Distribution Market by Region, 2022-2032 (US$ Bn, AGR (%))
Figure 20 Pharma Wholesale and Distribution Market by Product Type, 2022-2032 (US$ Bn, AGR (%))
Figure 21 Pharma Wholesale and Distribution Market by Distributor Type, 2022-2032 (US$ Bn, AGR (%))
Figure 22 Pharma Wholesale and Distribution Market by Type, 2022-2032 (US$ Bn, AGR (%))
Figure 23 Pharma Wholesale and Distribution Market by Type, 2022-2032 (US$ Bn, AGR (%))
Figure 24 Full-Line Wholesalers (FLWs) Market Forecast, 2022-2032 (US$ Bn, AGR (%))
Figure 25 Full-Line Wholesalers (FLWs) Market by Region, 2022-2032 (US$ Bn, AGR (%))
Figure 26 Short-Line Wholesalers (SLWs) Market Forecast, 2022-2032 (US$ Bn, AGR (%))
Figure 27 Short-Line Wholesalers (SLWs) Market by Region, 2022-2032 (US$ Bn, AGR (%))
Figure 28 Direct-to-Pharmacy (DTP) Market Forecast, 2022-2032 (US$ Bn, AGR (%))
Figure 29 Direct-to-Pharmacy (DTP) Market by Region, 2022-2032 (US$ Bn, AGR (%))
Figure 30 Hospitals, Clinics & Others Market Forecast, 2022-2032 (US$ Bn, AGR (%))
Figure 31 Hospitals, Clinics & Others Market by Region, 2022-2032 (US$ Bn, AGR (%))
Figure 32 Mail Orders Market Forecast, 2022-2032 (US$ Bn, AGR (%))
Figure 33 Mail Orders Market by Region, 2022-2032 (US$ Bn, AGR (%))
Figure 34 Other Types Market Forecast, 2022-2032 (US$ Bn, AGR (%))
Figure 35 Other Types Market by Region, 2022-2032 (US$ Bn, AGR (%))
Figure 36 Pharma Wholesale and Distribution Market by Product Type, 2022-2032 (US$ Bn, AGR (%))
Figure 37 Prescription Drugs Wholesaling & Distribution Market Forecast, 2022-2032 (US$ Bn, AGR (%))
Figure 38 Prescription Drugs Wholesaling & Distribution Market by Region, 2022-2032 (US$ Bn, AGR (%))
Figure 39 Antibiotics Wholesaling & Distribution Market Forecast, 2022-2032 (US$ Bn, AGR (%))
Figure 40 Antibiotics Wholesaling & Distribution Market by Region, 2022-2032 (US$ Bn, AGR (%))
Figure 41 OTC Products Wholesaling & Distribution Market Forecast, 2022-2032 (US$ Bn, AGR (%))
Figure 42 OTC Products Wholesaling & Distribution Market by Region, 2022-2032 (US$ Bn, AGR (%))
Figure 43 Antiseptics Wholesaling & Distribution Market Forecast, 2022-2032 (US$ Bn, AGR (%))
Figure 44 Antiseptics Wholesaling & Distribution Market by Region, 2022-2032 (US$ Bn, AGR (%))
Figure 45 Supplement Products Wholesaling & Distribution Market Forecast, 2022-2032 (US$ Bn, AGR (%))
Figure 46 Supplement Products Wholesaling & Distribution Market by Region, 2022-2032 (US$ Bn, AGR (%))
Figure 47 Other Product Types Wholesaling & Distribution Market Forecast, 2022-2032 (US$ Bn, AGR (%))
Figure 48 Other Product Types Wholesaling & Distribution Market by Region, 2022-2032 (US$ Bn, AGR (%))
Figure 49 Pharma Wholesale and Distribution Market by Distributor Type, 2022-2032 (US$ Bn, AGR (%))
Figure 50 Ethical/Branded Pharma Products Distributors Market Forecast, 2022-2032 (US$ Bn, AGR (%))
Figure 51 Ethical/Branded Pharma Products Distributors Market by Region, 2022-2032 (US$ Bn, AGR (%))
Figure 52 Generic Pharma Products Distributors Market Forecast, 2022-2032 (US$ Bn, AGR (%))
Figure 53 Generic Pharma Products Distributors Market by Region, 2022-2032 (US$ Bn, AGR (%))
Figure 54 Propaganda Cum Distribution (PCD) Franchise Market Forecast, 2022-2032 (US$ Bn, AGR (%))
Figure 55 Propaganda Cum Distribution (PCD) Franchise Market by Region, 2022-2032 (US$ Bn, AGR (%))
Figure 56 OTC/Institutional Supply Pharma Distributors Market Forecast, 2022-2032 (US$ Bn, AGR (%))
Figure 57 OTC/Institutional Supply Pharma Distributors Market by Region, 2022-2032 (US$ Bn, AGR (%))
Figure 58 Other Distributor Types Market Forecast, 2022-2032 (US$ Bn, AGR (%))
Figure 59 Other Distributor Types Market by Region, 2022-2032 (US$ Bn, AGR (%))
Figure 60 North America Pharma Wholesale and Distribution Market by Value, 2022-2032 (US$ Bn, AGR (%))
Figure 61 North America Pharma Wholesale and Distribution Market by Country, 2022-2032 (US$ Bn, AGR (%))
Figure 62 North America Pharma Wholesale and Distribution Market by Product Type, 2022-2032 (US$ Bn, AGR (%))
Figure 63 North America Pharma Wholesale and Distribution Market by Distributor Type, 2022-2032 (US$ Bn, AGR (%))
Figure 64 North America Pharma Wholesale and Distribution Market by Type, 2022-2032 (US$ Bn, AGR (%))
Figure 65 US Pharma Wholesale and Distribution Market by
